2023-09-03-世界卫生组织-WHO_BS_2023.2457_WHO_1st_International_Standard_TAFI,_Plasma_41页_837kb
报告摘要
-
Objective: The collaborative study aimed to establish an international reference standard for measuring TAFI (Thrombin Activatable Fibrinolysis Inhibitor) activity and antigen in plasma, avoiding inter-laboratory variability.
-
Key Activities:
- 10 laboratories from 7 countries measured TAFI activity and/or antigen using ampoules
A(candidate standard), normal controlB, low-TAFI controlC, and high-TAFI controlD. - Assays were bioanalyzed using statistical methods (Combistats software), yielding potency values relative to local standards, pooled plasma, or international units (IU).
- Independent quantification used isotope-dilution mass spectrometry (IDMS) to determine TAFI antigen in SI units (µg).
- 10 laboratories from 7 countries measured TAFI activity and/or antigen using ampoules
-
Proposed WHO 1st International Standard: Product code
17/200(SampleA), assigned:- TAFI:Activity: 0.87 IU per ampoule.
- TAFI:Antigen: 0.92 IU per ampoule.
- TAFI:Antigen (SI units): 7.43 µg per ampoule (expanded uncertainty with k=2 corresponds to 95% confidence).
-
Validation/Supporting Findings:
- Consistent results across 5,349 analyses from 12 months’ accelerated thermal stability testing.
- Short-term bench stability after reconstitution confirmed losses of ≤4.5% over 6 hours.
- Reproducibility showed low inter-laboratory variability (GCV ≤5.06%), increasing confidence in the standard.
- IDMS values for Sample
Ashowed low variability (CV=4.5%), affirming its suitability as an SI-unit reference.
-
Recommendations:
- Studies should complete potency assays within 4 hours after standard reconstitution.
- IDMS should be implemented for harmonizing TAFI antigen quantification globally.
Summary [WHO/BS/2023.2457]
This study successfully calibrated a WHO 1st International Standard (Sample A, code 17/200) for TAFI plasma. Key findings include:
- Establishment of standardized TAFI potency values (activity: 0.87 IU/ampoule; antigen: 0.92 IU/ampoule; antigen: 7.43 µg/ampoule) with high robustness.
- Stability results (thermal degradation and bench stability) support use for harmonizing TAFI measurements across laboratories.
- IDMS verification aligns with the assigned SI-unit value.
展开完整摘要
试读结束,高清完整版pdf/doc/ppt,请点下载